COLUMBIA, Md.—The Foundation Fighting Blindness announced the promotion of Jason Menzo to president and chief operating officer, effective immediately. “Since joining the Foundation in 2018, Menzo has had a profound positive impact on redefining the non-profit's operations, including fiscal, fundraising, communications, and managerial operations, the organization said in an announcement. "He is recognized by colleagues and constituents for his passionate leadership style and ability to create innovative partnerships. In addition, he was involved in the formation of the RD Fund (Retinal Degeneration Fund), the venture arm of Foundation Fighting Blindness, which was created to further serve its mission. As well, Mr. Menzo is one of the founders of Opus Genetics, the first spin-off company internally conceived and launched by the RD Fund to further the Foundation's mission.”

David Brint, chair of the Foundation Fighting Blindness board of directors, commented, "We are excited to have Jason as president, along with continuing his current operational responsibilities. He has shown tremendous dedication to the mission and causes of the organization during his tenure."
Foundation chief executive officer Benjamin Yerxa, PhD, said, "Jason's impact on the Foundation has been undeniable. His ability to engage and influence the culture of internal staff alongside our constituents, while also guiding operational and fundraising efforts, has benefitted the Foundation and our mission immensely."
Prior to joining the Foundation, Menzo was a seasoned health care executive, having led the successful development and launch of several notable ophthalmic companies and brands. He has been previously recognized as one of the "50 Outstanding Innovators in Pharma (marketing)" and as "Ophthalmic Marketer of the Year" by Product Manager 360, a trade publication. In 2019, he was recognized at the Visionary Honor Awards, an annual charity event hosted by Insightful Visionaries that acknowledges leaders for their outstanding service to the blind and visually impaired community.